Epilepsy is a life-threatening disorder, with 10% of the world's population would experience at least one seizure during their lives. This review summarises antiepileptic drugs focused on GABAergic and glutamatergic synaptic transmission. GABA and glutamate receptors are the primary targets for those antiepileptic drugs (AEDs). Three types of GABA receptors with structural and metabolically differences, GABAA and GABAC, are ionotropic receptors with different reactions to antagonists, and GABAB receptors are G-protein coupled receptors (GPCR). Two types of glutamate receptors are investigated: ionotropic glutamate receptors (iGluR) and metabolic glutamate receptors (mGluR). iGluRs are channels receptor with a central pore allowing ions to pass through. There are three main types: AMPA receptors, kainate receptors, and NMDA receptors. mGluRs are GPCRs with eight members, which can be classified into three groups: group I, group II, and group III. These structures and their functions are explained further with relevant target drugs.
|